ENTPD1 and systemic lupus erythematosus: ENTPD1/CD39−/− and CD73−/− mice show more pronounced endothelial cell dysfunction and exaggerated neutrophil extracellular “trap” release in response to intraperitoneal administration of pristane, in a model of lupus, when compared to wild type (WT) controls.